Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $84.29 M | 227.82% |
2023 | $25.71 M | 15.22% |
2022 | $22.31 M | -30.83% |
2021 | $32.26 M | -42.59% |
2020 | $56.2 M | 156.83% |
2019 | $21.88 M | -55.79% |
2018 | $49.49 M | 223.95% |
2017 | $15.27 M | -77.94% |
2016 | $69.25 M | 11.56% |
2015 | $62.07 M | -15.95% |
2014 | $73.85 M | 760.63% |
2013 | $8.58 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Novartis NVS | $20.77 M | $81.53 M | ๐จ๐ญ Switzerland |
Pfizer PFE | $13.91 M | $0.31 B | ๐บ๐ธ USA |
Eli Lilly LLY | $54.05 M | $0.11 B | ๐บ๐ธ USA |
Amgen AMGN | $52.24 M | $0.21 B | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $0.54 M | $3.11 M | ๐บ๐ธ USA |
Geron GERN | $11.56 M | $16.14 M | ๐บ๐ธ USA |
CTI BioPharma
CTIC | N/A | $43.8 M | ๐บ๐ธ USA |
AVEO Oncology
AVEO | N/A | $0.04 M | ๐บ๐ธ USA |
Ardelyx ARDX | $3.95 M | $30.45 M | ๐บ๐ธ USA |